These results help characterize the mechanism of CAN in chronic ischemic heart disease and, thus, identify directions for further research in patients treated with SGLT-2 inhibitors. The gene discussed is SLC5A2; the disease is Crouzon syndrome-acanthosis nigricans syndrome.